SAN RAFAEL, Calif.,
Jan. 3, 2018 /PRNewswire/ -- BioMarin
Pharmaceutical Inc. (NASDAQ: BMRN), today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will
participate in the 36th Annual J.P. Morgan Healthcare
Conference on Monday, January 8, 2018
at 8:30 am PT, or 11:30 am ET, in San
Francisco, California. To access the live webcast, please
visit the investor section of the BioMarin
website, www.biomarin.com. A replay will also be archived on
the site for at least one week following the event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of six commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical
Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-present-at-36th-annual-jp-morgan-healthcare-conference-in-san-francisco-300576826.html
SOURCE BioMarin Pharmaceutical Inc.